Plasma renin activity-guided strategy for the management of hypertension (Q38001331)

26 August 2017

Plasma renin activity-guided strategy for the management of hypertension (English)

1 reference

26 August 2017

Nicole Olson

1

1 reference

26 August 2017

Beth DeJongh

series ordinal

2

1 reference

26 August 2017

Augustus Hough

series ordinal

3

1 reference

26 August 2017

David Parra

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

9 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

32

1 reference

26 August 2017

5

1 reference

26 August 2017

446-455

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

26 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Using plasma renin (PRA) testing to design follow-up drug treatment strategies in hypertensive patients already taking antirenin system drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.2012.01031.X

10.1002/J.1875-9114.2012.01031.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference